Clinical Trial

Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders : KALIGO+

Study acronym: KALIGO+
Recruiting
View on ClinicalTrials.gov →
Summary
Writing is a fundamental skill, crucial to a child's success at school and the development of independence. Around 30% of children present difficulties in learning to write, and for some of them (10%), these difficulties persist for a long time. Adapted learning can improve their handwriting. Initial studies into the use of new technologies (tablets, virtual reality headsets) have shown that they can help children learn to write. Attractive to children, these interfaces make it possible to apply new paradigms (e.g. enrichment of feedback \[sonification\], variation of writing media) that have proved effective, mainly with children with 'typical' development. The Kaligo+ solution is based on the latest scientific advances to offer an innovative approach to learning to write, particularly for children with significant difficulties in this area. This study proposes to test the benefits of the Kaligo+ solution on 15 children with writing difficulties. The main objective of this pilot study is to demonstrate improved writing performance following use of the Kaligo+ solution in children aged 6 to 11 with writing difficulties, using a Single Case Experimental Design (SCED) methodology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-03-27
Trial Details
NCT Number NCT06858566
Lead Sponsor Fondation Ildys
Conditions Writing Disorder
Enrollment 15 participants
Start Date 2025-03-21
Primary Completion 2027-02-24 (estimated)
Study Completion 2027-02-24 (estimated)
Updated on ClinicalTrials.gov 2025-03-28